Archived articles


Health Policy Forum
JHU to host conversation with AAAS CEO Sudip Parikh
Published July 19, 2023
He will join Theodore DeWeese, interim dean of the School of Medicine, on July 28 to discuss the future of science in the U.S. and how artificial intelligence is fueling advances in research
3 questions
OTC birth control pill approved by FDA
Published July 13, 2023
The ruling has the potential to reduce barriers and increase equity in access to contraception—if it is affordable, says Johns Hopkins expert Carolyn Sufrin
The science and safety of marijuana
Published July 10, 2023
Experimental psychologist Ryan Vandrey discusses the science and safety of recreational cannabis on the heels of legalization in Maryland
Global health
The chemistry of mosquito attraction
Published July 6, 2023
New discoveries by Johns Hopkins researchers about mosquitoes' human scent preferences could lead to novel malaria interventions
Interdisciplinary scholar
Putting the brakes on cancer progression
Published June 27, 2023
Mikala Egeblad, who studies how tumor microenvironments influence the growth and metastasis of cancer cells, joins the School of Medicine as a Bloomberg Distinguished Professor
The case for more screen time
Published Summer 2023
A pair of recent studies looks at how social isolation affects older adults / Johns Hopkins Magazine
A history of healing
Published Summer 2023
Kay Redfield Jamison discusses her latest book, which takes a nonlinear approach to cataloging the history of psychotherapy / Johns Hopkins Magazine
The artful mind
Published Summer 2023
In their new book, authors Susan Magsamen, founder and director of the International Arts + Mind Lab, and Ivy Ross contend that making and experiencing art can help us flourish / Johns Hopkins Magazine
A year without Roe
Published June 21, 2023
Hopkins experts examine the abortion rights landscape a year after the U.S. Supreme Court overturned Roe v. Wade
Innovative care
Hopkins AITC announces awardees of second funding round
Published June 16, 2023
Grant recipients–hailing from academia, industry, and clinical practice—will receive funding to develop new devices and other aging-related innovations